Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vinorelbine + Trastuzumab in Metastatic HER2+ Breast Cancer
NCT01242449Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Nov 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in breast cancer, sponsored by Vejle Hospital. Started Nov 2010; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01242449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01242449.